Leaders in characterization

Analytical solutions for biopharmaceutical characterization and control Your partner on every step of your journey Together we can address the challenges of biotherapeutic drug development Your molecules are complex Biotherapeutics such as monoclonal antibodies, biosimilars, antibody-drug conjugates, and nucleotide-based therapies…

CASE STUDY 73683 Deploying the multi-attribute method (MAM) across sites at Pfizer Pfizer is building the MAM lab-of-the-future Pfizer is a leading research-based biopharmaceutical company. At Pfizer, scientific principles, innovation, and the company’s global resources are applied to bring therapies…

20 30 Conjugation Site (ADC) 40 32 340 20 0 0 50 33 0 31 40 31 30 350 30 0 0 31 0 60 70 30 0 0 290 30 90 270 0 12 270 250 24 0 260…

Biopharma By your side Accelerating biotherapeutic development Enabling every step of your biotherapeutic development We equip you to overcome today’s and tomorrow’s challenges with tools and expertise to advance life-changing biotherapeutics to market faster than ever before. Your molecules are…